Projects Pipeline

logo
Address

The National Institute for Biotechnology
in the Negev Ltd.
Ben-Gurion University of the Negev

Research topicPrincipal Investigator
TRAMMICS: Target Receptor Activating Membrane Moiety with Inert Cytoplasmic Stub
Learn More
Profs. Angel Porgador, Alon Monsonego
LENTGH: Life Extension Not (just) To Growth Hormone Learn MoreProf. Angel Porgador
CARTIV: Chimeric Antigen Receptor Within Tumor-Induced Vector (Promoter-Based Targeting of CAR Expression to Tumor Site) Learn MoreProf. Angel Porgador, Dr. Roi Gazit
Targeting Translation Inhibition to Inhibit Tumor Adaptation to Metabolic Stress Learn MoreDr. Barak Rotblat
A Novel PKC-Inhibitor with Anti-Tumorigenic Activity Learn MoreProfs. Esti Yeger-Lotem, Etta Livneh
Protein Engineering Using an Expanded Genetic Code Learn MoreDr. Eyal Arbely
Anti-PSMA ADC Nanobodies for Therapy and Imaging Learn MoreDrs. Niv Papo, Eyal Arbely
Developing A Novel Target Therapy for EGFR Mutated Lung Cancer Learn MoreProf. Nir Peled
Dual-Specific R-Protein as an Anti-Resorptive Treatment for Bone-Related Disorders Learn MoreDrs. Niv Papo, Noam Levaot
Combinatorial Protein Engineering of Proteolytically Resistant Mesotrypsin Inhibitors for Cancer Therapy Learn MoreDr. Niv Papo
Novel Drug Target Discovery Through Genetic Studies of Unique Inbred Communities Learn MoreProfs. Ohad Birk, Ruti Parvari
Generation of Tailor-Made Leukemia Models in Immune-Competent Mice Learn MoreDr. Roi Gazit
Fortis: A New Rapid Screening Assay for Cognitive Enhancement Compounds Learn MoreDr. Shira Knafo
Deimmunization of Therapeutic Proteins Learn MoreProf. Amir Aharoni, Dr. Tomer Hertz
Rapid Diagnostic Assay for Antibody Dependent Enhancement Following Secondary Flaviviruses Infection Learn MoreDr. Tomer Hertz
Novel Profiling of Influenza Immune History: Implications on Vaccine-Induced Immunity and Efficacy Learn MoreDr. Tomer Hertz
Novel Biomarker Proteins for CLL and Lung Cancer: Impact on Diagnosis, Prognosis, and Treatment Learn MoreProf. Varda Shoshan-Barmatz
Mitochondrial VDAC: A New Strategy for Fighting Steatosis and NASH Learn MoreProf. Varda Shoshan-Barmatz
Selective Induction of Cancer Cell Death by VDAC1-Based Peptides Learn MoreProf. Varda Shoshan-Barmatz
New Anti-Cancer Therapeutic Strategies by Silencing SMAC/DIABLO Learn MoreProf. Varda Shoshan-Barmatz
Compounds Targeting the Mitochondrial Protein VDAC1: A Therapeutic Strategy in Neurodegenerative Diseases Learn MoreProf. Varda Shoshan-Barmatz
Treating Cancer with VDAC1-Based siRNA; Reprograming Metabolism and Reversing Oncogenic Properties Learn MoreProf. Varda Shoshan-Barmatz